Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells

被引:3
|
作者
Rosado-Galindo, Heizel [1 ]
Domenech, Maribella [1 ,2 ]
机构
[1] Univ Puerto Rico Mayaguez, Bioengn Program, Mayaguez, PR 00682 USA
[2] Univ Puerto Rico Mayaguez, Dept Chem Engn, Mayaguez, PR 00682 USA
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2023年 / 11卷
基金
美国国家卫生研究院;
关键词
topography; EGFR signaling; TNBC; secretome; stemness; PHASE-II; TARGETED THERAPY; GROWTH; PROLIFERATION; RESISTANCE; PROMOTES; OVEREXPRESSION; CHALLENGES; SIGNATURE; YAP/TAZ;
D O I
10.3389/fcell.2023.1124250
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Cancer stem cells (CSC), a major culprit of drug-resistant phenotypes and tumor relapse, represent less than 2 % of the bulk of TNBC cells, making them difficult to isolate, study, and thus, limiting our understanding of the pathogenesis of the disease. Current methods for CSC enrichment, such as 3D spheroid culture, genetic modification, and stem cell conditioning, are time consuming, expensive, and unsuitable for high-throughput assays. One way to address these limitations is to use topographical stimuli to enhance CSC populations in planar culture. Physical cues in the breast tumor microenvironment can influence cell behavior through changes in the mechanical properties of the extracellular matrix (ECM). In this study, we used topographical cues on polystyrene films to investigate their effect on the proteome and stemness of standard TNBC cell lines.Methods: The topographical polystyrene-based array was generated using razor printing and polishing methods. Proteome data were analyzed and enriched bioprocesses were identified using R software. Stemness was assessed measuring CD44, CD24 and ALDH markers using flow cytometry, immunofluorescence, detection assays, and further validated with mammosphere assay. EGF/EGFR expression and activity was evaluated using enzyme-linked immunosorbent assay (ELISA), immunofluorescence and antibody membrane array. A dose-response assay was performed to further investigate the effect of surface topography on the sensitivity of cells to the EGFR inhibitor.Results: Surface roughness enriched the CSC population and modulated epidermal growth factor receptor (EGFR) signaling activity in TNBC cells. Enhanced proliferation of MDA-MB-468 cells in roughness correlated with upregulation of the epidermal growth factor (EGF) ligand, which in turn corresponded with a 3-fold increase in the expression of EGFR and a 42% increase in its phosphorylation compared to standard smooth culture surfaces. The results also demonstrated that phenotypic changes associated with topographical (roughness) stimuli significantly decreased the drug sensitivity to the EGFR inhibitor gefitinib. In addition, the proportion of CD44+/CD24-/ALDH+ was enhanced on surface roughness in both MDA-MB-231 and MDA-MB-468 cell lines. We also demonstrated that YAP/TAZ activation decreased in a roughness-dependent manner, confirming the mechanosensing effect of the topographies on the oncogenic activity of the cells.Discussion: Overall, this study demonstrates the potential of surface roughness as a culture strategy to influence oncogenic activity in TNBC cells and enrich CSC populations in planar cultures. Such a culture strategy may benefit high-throughput screening studies seeking to identify compounds with broader tumor efficacy.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer
    Bai, Xupeng
    Liu, Jiarui
    Zhou, Shujie
    Wu, Lingzhi
    Feng, Xiaojie
    Zhang, Pumin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [32] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
  • [33] A perspective on anti-EGFR therapies targeting triple-negative breast cancer
    Nakai, Katsuya
    Hung, Mien-Chie
    Yamaguchi, Hirohito
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (08): : 1609 - 1623
  • [34] Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
    Zhang, Minghui
    Zhang, Xiaosan
    Zhao, Shu
    Wang, Yan
    Di, Wenyu
    Zhao, Gangling
    Yang, Maopeng
    Zhang, Qingyuan
    TARGETED ONCOLOGY, 2014, 9 (04) : 349 - 357
  • [35] Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells
    Xu, Zhen
    Liu, Cuiui
    Zhao, Qian
    Lu, Jinhui
    Ding, Xin
    Luo, An
    He, Jia
    Wang, Guangxue
    Li, Yuan
    Cai, Zhaoqing
    Wang, Zhongrui
    Liu, Junjun
    Liu, Suling
    Li, Wenshu
    Yu, Zuoren
    PHARMACOLOGICAL RESEARCH, 2020, 152
  • [36] Prospectives of mirna gene signaling pathway in triple-negative breast cancer
    Chakkaravarthi, Kamali
    Ramesh, Rajashree
    Palaniyandi, Thirunavukkarasu
    Baskar, Gomathy
    Viswanathan, Sandhiya
    Wahab, Mugip Rahaman Abdul
    Surendran, Hemapreethi
    Ravi, Maddaly
    Sivaji, Asha
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [37] Fish Oil and Selenium with Doxorubicin Modulates Expression of Fatty Acid Receptors and Selenoproteins, and Targets Multiple Anti-Cancer Signaling in Triple-negative Breast Cancer Tumors
    Guo, Chih-Hung
    Shih, Min-Yi
    Chung, Chieh-Han
    Lin, Yi-Chun
    Fan, Ciou-Ting
    Peng, Chia-Lin
    Chen, Pei-Chung
    Hsia, Simon
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (14): : 2044 - 2057
  • [38] Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib
    Wang, Xinzhao
    Song, Hongkuan
    Yu, Qian
    Liu, Qi
    Wang, Leilei
    Liu, Zhaoyun
    Yu, Zhiyong
    ONCOLOGY REPORTS, 2015, 33 (02) : 526 - 532
  • [39] Targeting Akt3 Signaling in Triple-Negative Breast Cancer
    Chin, Y. Rebecca
    Yoshida, Taku
    Marusyk, Andriy
    Beck, Andrew H.
    Polyak, Kornelia
    Toker, Alex
    CANCER RESEARCH, 2014, 74 (03) : 964 - 973
  • [40] Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
    Agnello, Lisa
    Tortorella, Silvia
    D'Argenio, Annachiara
    Carbone, Clarissa
    Camorani, Simona
    Locatelli, Erica
    Auletta, Luigi
    Sorrentino, Domenico
    Fedele, Monica
    Zannetti, Antonella
    Franchini, Mauro Comes
    Cerchia, Laura
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)